FEB 05, 2014 6:00 PM PST

Approaches to Vendor Assessment in Biomedical Research

Speaker
  • Executive Director, Veterinary Science and Animal Welfare, WuXi AppTec (Suzhou) Co., Ltd.
    Biography

       
      Scout earned her Bachelor of Science degree in biochemistry/cell biology from the University of California, San Diego in 1995, and her V.M.D. degree from the University of Pennsylvania, School of Veterinary Medicine in 2000. She then completed a post-doctoral training program in laboratory animal medicine and received a Master of Science degree in Comparative Medicine from the University of Washington in 2004. As a laboratory animal veterinarian, she supported different business segments within Charles River until 2011, including Animal Welfare and Training, Genetically Engineered Models and Services, Surgical Services, Phenotyping Services, Discovery and Imaging Services, and Preclinical Services. Scout became a Diplomate in the American College of Laboratory Animal Medicine in 2005 and remains active within several professional organizations which are committed to responsible animal use in research, testing, and teaching. In August of 2012 Scout joined WuXi AppTec in Suzhou and currently serves as the Executive Director of Veterinary Science and Animal Welfare.
       

    Abstract

    For the purpose of ensuring research integrity, data reproducibility, and animal welfare, institutions that conduct animal research have the responsibility to evaluate vendors that provide laboratory animals, diet, bedding, and other products that have the potential to impact study outcome. Vendor assessment is therefore an integral component of any research institution's Animal Care and Use Program. The purpose of this presentation is to demonstrate the approaches to vendor qualification, including key areas to focus on, types of questions to ask, what to look for during facility tours, and post-visit follow-up expectations. By the end of the session, attendees should gain a better understanding of the vendor evaluation process, and be able to assess whether current internal qualification program will meet animal user expectations.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources